Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (10): 922-924.DOI: 10.3969/j.issn.1673-8640.2016.010.019
• Orginal Article • Previous Articles Next Articles
Received:2015-12-16
Online:2016-10-20
Published:2016-11-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.010.019
| 组别 | 基因型 | 等位基因 | ||||
|---|---|---|---|---|---|---|
| CC | CT | TT | C | T | ||
| 正常对照组 | 60（20.76） | 145（50.17） | 84（29.07） | 265（45.85） | 313（54.15） | |
| 急性脑梗死组 | 21（15.79） | 57（42.86） | 55（41.35）* | 99（37.22） | 167（62.78） | |
| 高血压组 | 5（11.11） | 22（48.89） | 18（40.00） | 32（35.56） | 58（64.44） | |
| 癫痫组 | 11（19.64） | 19（33.93） | 26（46.43）* | 41（36.61） | 71（63.39） | |
| 视神经病变组 | 9（25.71） | 19（54.29） | 7（20.00） | 37（52.86） | 33（47.14） | |
| 组别 | 基因型 | 等位基因 | ||||
|---|---|---|---|---|---|---|
| CC | CT | TT | C | T | ||
| 正常对照组 | 60（20.76） | 145（50.17） | 84（29.07） | 265（45.85） | 313（54.15） | |
| 急性脑梗死组 | 21（15.79） | 57（42.86） | 55（41.35）* | 99（37.22） | 167（62.78） | |
| 高血压组 | 5（11.11） | 22（48.89） | 18（40.00） | 32（35.56） | 58（64.44） | |
| 癫痫组 | 11（19.64） | 19（33.93） | 26（46.43）* | 41（36.61） | 71（63.39） | |
| 视神经病变组 | 9（25.71） | 19（54.29） | 7（20.00） | 37（52.86） | 33（47.14） | |
| 组别 | 例数 | CC基因型 | CT基因型 | TT基因型 |
|---|---|---|---|---|
| 正常对照组 | 289 | 11.64±0.76* | 11.78±0.49* | 19.82±1.48 |
| 急性脑梗死组 | 133 | 13.68±1.33*# | 22.50±2.15*△ | 42.82±5.48△ |
| 高血压组 | 45 | 10.99±1.10* | 13.96±1.05* | 24.24±3.36 |
| 癫痫组 | 56 | 11.44±1.19*# | 23.88±3.25*△ | 39.59±5.21△ |
| 视神经病变组 | 35 | 13.42±2.41* | 24.12±4.21*△ | 33.26±8.21△ |
| 组别 | 例数 | CC基因型 | CT基因型 | TT基因型 |
|---|---|---|---|---|
| 正常对照组 | 289 | 11.64±0.76* | 11.78±0.49* | 19.82±1.48 |
| 急性脑梗死组 | 133 | 13.68±1.33*# | 22.50±2.15*△ | 42.82±5.48△ |
| 高血压组 | 45 | 10.99±1.10* | 13.96±1.05* | 24.24±3.36 |
| 癫痫组 | 56 | 11.44±1.19*# | 23.88±3.25*△ | 39.59±5.21△ |
| 视神经病变组 | 35 | 13.42±2.41* | 24.12±4.21*△ | 33.26±8.21△ |
| 基因型 | 高Hcy[例（%）] | OR值（95%CI） | P值 |
|---|---|---|---|
| CC | 39（36.8） | 0.48（0.31~0.75） | 0.001 |
| CT | 117（44.7） | 0.61（0.43~0.85） | 0.003 |
| TT | 130（68.4） | 2.94（2.04~4.26） | 0.000 |
| 基因型 | 高Hcy[例（%）] | OR值（95%CI） | P值 |
|---|---|---|---|
| CC | 39（36.8） | 0.48（0.31~0.75） | 0.001 |
| CT | 117（44.7） | 0.61（0.43~0.85） | 0.003 |
| TT | 130（68.4） | 2.94（2.04~4.26） | 0.000 |
| [1] | 何锋,顾海勇,龚丁旭,等. 叶酸代谢通路相关酶基因多态性与先天性心脏病的研究进展[J]. 中国分子心脏病学杂志,2012,12(4):249-253. |
| [2] | FROSST P,BLOM HJ,MILOS R,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase[J]. Nat Genet,1995,10(1):111-113. |
| [3] | 瞿国英,林炜炜,戴越刚. 同型半胱氨酸水平与脑梗死患者传统危险因素的相关性分析[J]. 检验医学,2013,28(2):102-105. |
| [4] | 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中国全科医学,2011,14(35):4013-4017. |
| [5] | 温绍君,张蓓. 高血压的正确诊断及恰当治疗[J]. 中华老年心脑血管病杂志,2014,16(4):337-339. |
| [6] | 张青,聂莉媛,孙金,等. 成年癫痫患者体质类型与抑郁状况的相关性探析[J]. 中华中医药杂志,2015,30(5):1680-1683. |
| [7] | 钟毅敏,于强,欧杰雄,等. 缺血性视神经病变临床分析[J]. 中国实用眼科杂志,2003,21(4):269-272. |
| [8] | SELHUB J,JACQUES PF,WILSON PW,et al.Vitamin status and intake as primary determinants of homocysteinemia in an elderly population[J]. JAMA,1993,270(22):2693-2698. |
| [9] | WANG Y,LI X,QIN X,et al.Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years[J]. Br J Nutr,2013,109(7):1284-1293. |
| [10] | QIN X,LI J,CUI Y,et al.MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults[J]. Nutr J,2012,11:2. |
| [11] | GIL-PRIETO R,HERNANDEZ V,CANO B,et al.Plasma homocysteine in adolescents depends on the interaction between methylenetetrahydrofolate reductase genotype,lipids and folate:a seroepidemiological study[J]. Nutr Metab (Lond),2009,6:39. |
| [12] | 王春霞, 张轶华. 急性脑梗死患者血清同型半胱氨酸、尿酸及血脂水平的变化[J]. 检验医学,2015,30(3):303-304. |
| [13] | 肖艳群,蒋玲丽,陆青,等. 亚甲基四氢叶酸还原酶基因多态性及血浆同型半胱氨酸水平与脑血管病的关系[J]. 检验医学,2006,21(3):201-204. |
| [14] | HOLMES MV,NEWCOMBE P,HUBACEK JA,et al.Effect modification by population dietary folate on the association between MTHFR genotype,homocysteine,and stroke risk:a meta-analysis of genetic studies and randomised trials[J]. Lancet,2011,378(9791):584-594. |
| [15] | MURAKAMI H,IEMITSU M,SANADA K,et al.Associations among objectively measured physical activity,fasting plasma homocysteine concentration, and MTHFR C677T genotype[J]. Eur J Appl Physiol,2011,111(12):2997-3005. |
| [16] | LI Z,SUN L,ZHANG H,et al.Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke,but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke:a multicenter case-control study in China[J]. Stroke,2003,34(9):2085-2090. |
| [17] | FEKIH-MRISSA N,MRAD M,KLAI S,et al.Methylenetetrahydrofolate reductase(C677T and A1298C) polymorphisms,hyperhomocysteinemia,and ischemic stroke in Tunisian patients[J]. J Stroke Cerebrovasc Dis,2013,22(4):465-469. |
| [18] | 唐仪,陈慧,吴小盈. N5,10-亚甲基四氢叶酸还原酶基因多态性与原发性高血压病的关系研究[J]. 中国分子心脏病学杂志,2007,7(4):205-207. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
